Curocell

Developer of immune cell therapies

placeYuseong District, Hoseo, South Korea calendar_todayFounded 2016 groups102 employees language curocellbtx.com

Registered entities

Social engagement

Social engagement: 774 social following, 6 posts in the last 12 months — top 10% of its industry.

Investor mix

23 investors on record; lead investors include Atinum Investment, DS, Seoul Investment Partners, QUAD.

Investor typeCountShare
Venture capital1148%
Private equity313%
Other / undisclosed939%

Recent activity

14 Jun 2026
Milestone
regulatory
30 Apr 2026
Milestone
regulatory
3 Mar 2026
Milestone
regulatory
Coming soon